| Today, Wed, Feb 10, 2010 | | • | Crucell N.V. ADS Q4 2009 Earnings Call Transcript
at Seeking Alpha (Wed 12:58am)
| | Tue, Feb 9, 2010 | | • | UPDATE - Crucell seeking new growth engine, to boost R&D
at Reuters (Tue 9:01pm)
| | • | Q4 2009 Crucell Earnings Release - Time Not Supplied
CCBN (Tue 8:07pm)
| | • | Crucell Announces Record Revenues and Profits for Full Year 2009
Marketwire (Tue 3:17pm)
| | Sat, Feb 6, 2010 | | • | Big Pharma's Shot In The Arm
at CNBC (Sat, Feb 6)
| | Tue, Feb 2, 2010 | | • | Crucell to Release Fourth Quarter and Full Year 2009 Results on Tuesday February 9, 2010
Marketwire (Tue, Feb 2)
| | Wed, Jan 27, 2010 | | • | Is the Best of Johnson & Johnson Behind It?
at Motley Fool (Wed, Jan 27)
| | Tue, Jan 19, 2010 | | • | Zacks #5 Rank Additions for Tuesday
Zacks.com (Tue, Jan 19)
| | Tue, Jan 12, 2010 | | • | Crucell N.V. downgraded by Jefferies & Co
Briefing.com (Tue, Jan 12)
| | Wed, Nov 18, 2009 | | • | Vaccines on horizon for AIDS, Alzheimer's, herpes
AP (Wed, Nov 18)
| | • | Vaccines on horizon for AIDS, Alzheimer's, herpes
AP (Wed, Nov 18)
| | Mon, Nov 16, 2009 | | • | Crucell launches global brand to reflect and reinforce its leading position in healthcare innovation
Marketwire (Mon, Nov 16)
| | Thu, Nov 5, 2009 | | • | TapImmune Signs License Agreement With Crucell N.V.
GlobeNewswire (Thu, Nov 5)
| | Tue, Nov 3, 2009 | | • | Crucell Earnings Presentation Call scheduled for 8:00 am ET today
CCBN (Tue, Nov 3)
| | • | Calmune and Crucell Enter Exclusive Research Collaboration
Marketwire (Tue, Nov 3)
| | • | Crucell Announces Third Quarter 2009 Results
Marketwire (Tue, Nov 3)
| | Thu, Oct 29, 2009 | | • | 2 Stocks Hitting Low Notes
at Motley Fool (Thu, Oct 29)
| | Tue, Oct 27, 2009 | | • | Crucell to Release Q3 2009 Results on Tuesday November 3, 2009
Marketwire (Tue, Oct 27)
| | Wed, Oct 21, 2009 | | • | Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris
Marketwire (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | Crucell Rabies Monoclonal Antibody Combination: Positive Results Philippines Phase II Study Presented at RITA Conference
Marketwire (Tue, Oct 20)
| | Older Headlines | |
| |
|
Help
Headlines
